{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:59:08Z","timestamp":1789520348096,"version":"build-2803163510"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Seit dem Oktober 2021 k\u00f6nnen in Deutschland alle Versicherten ab 35 Jahren einmalig bei der Gesundheitsuntersuchung (GU) auf Hepatitis B (HBV) und C (HCV) getestet werden \u2013 unabh\u00e4ngig von spezifischen Risiken. Dies ist ein gro\u00dfer Beitrag zur Krebspr\u00e4vention und zur Elimination dieser Infektionen. In den USA wird von den Centers for Disease Control and Prevention seit April 2020 ein einmaliges Screening auf HCV f\u00fcr alle Erwachsenen ab dem Alter von 18 Jahren, zus\u00e4tzlich zu einer Testung bei bekannten Risiken empfohlen, da ein erheblicher Anteil der Betroffenen nicht durch eine risikobasierte Testung entdeckt werden kann. Entsprechende Empfehlungen f\u00fcr ein universelles HBV-Screening werden z.Z. von der CDC erarbeitet. Nach den vorliegenden Daten ist ein solches Screening in Kombination mit einem Angebot einer HBV-Impfung auch in Deutschland f\u00fcr das Erreichen der WHO-Eliminationsziele bis zum Jahre 2030 notwendig. Ein derartiges Testangebot auf HBV und HCV f\u00fcr alle Erwachsenen erscheint auch ethisch geboten, geboten, um durch fr\u00fchzeitige Therapien m\u00f6glichst viele lebensbedrohliche Folgen bzw. Todesf\u00e4lle zu verhindern.<\/jats:p>","DOI":"10.1055\/a-1972-4118","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:01:22Z","timestamp":1675814482000},"page":"175-182","source":"Crossref","is-referenced-by-count":1,"title":["Ein umfassendes Screening auf Hepatitis B und C ist eine effektive Krebspr\u00e4vention und die Voraussetzung f\u00fcr die Elimination dieser Infektionen \u2013 Daten und Anmerkungen zu einer Diskussion"],"prefix":"10.1055","volume":"148","author":[{"given":"Ingmar","family":"Wolffram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"ref2","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMra1810477","article-title":"Global Elimination of Chronic Hepatitis","volume":"380","author":"DL Thomas","year":"2019","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00265-4","article-title":"Global progress Report on HIV, viral hepatitis and sexually transmitted infections","author":"World Health Organization","year":"2021"},{"issue":"02","key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC Recommendation for Hepatitis C screening Among Adults \u2013 United States 2020","volume":"69","year":"2020","journal-title":"Recommendations and Reports"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.cgh.2018.08.080","article-title":"Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens","volume":"17","author":"MH Eckman","year":"2019","journal-title":"Clinl Gastroenterol and Hepatol"},{"issue":"11","key":"ref8","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/cid\/cir199","article-title":"The cost-effectiveness of Screening for chronic hepatitis B Infection in the United States","volume":"52","author":"M Eckman","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jhep.2015.01.011","article-title":"Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios","volume":"62","author":"I Wolffram","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"38","key":"ref12","first-page":"A-1584","article-title":"WHO-Empfehlungen: Hepatitis C lie\u00dfe sich eliminieren","volume":"119","author":"M Lenzen-Schulte","year":"2022","journal-title":"Dtsch \u00c4rzteblatt"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00103-021-03478-8","article-title":"Epidemiologie der Virushepatitiden A bis E in Deutschland","volume":"65","author":"S Dudareva","year":"2022","journal-title":"Bundesgesundheitsblatt, Gesundheitsforschung, Geesundheitsschutz"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fpubh.2020.00424","article-title":"Prevalence of Hepatitis B, C and D in Germany: Results From a Scoping Review","volume":"8","author":"I Sperle","year":"2020","journal-title":"Front Public Health"},{"issue":"07","key":"ref16","doi-asserted-by":"publisher","first-page":"e41206","DOI":"10.1371\/journal.pone.0041206","article-title":"High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: a prospective screening analysis of 28,809 patients","volume":"7","author":"J Vermehren","year":"2012","journal-title":"PLoS One"},{"issue":"06","key":"ref17","first-page":"85","article-title":"The ethiology diagnoses and prevention of liver cirrhosis \u2013 part 1 of a series on liver cirrhosis","volume":"110","author":"J Wiegand","year":"2013","journal-title":"Dtsch \u00c4rzteblatt Int"},{"issue":"09","key":"ref19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/23744235.2020.1766104","article-title":"Mortality from liver diseases attributable to hepatitis B and C in the EU\/EEA \u2013 descriptive analysis and estimation of 2015 baseline","volume":"52","author":"O M\u00e5rdh","year":"2020","journal-title":"Infect Dis"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jvh.13680","article-title":"Updated Epidemiologie of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany","volume":"29","author":"TL Tergast","year":"2022","journal-title":"J Viral Hepat"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1055\/a-0599-1320","article-title":"S 3 \u2013Leitlinie der DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis C Virusinfektion","volume":"56","year":"2018","journal-title":"Z Gastroenterol"},{"issue":"32","key":"ref24","first-page":"645","volume":"62","author":"Centers for Disease Control and Prevention (CDC) \u2013 Locations and reasons for initial testing for Hepatitis C infection \u2013 chronic hepatitis cohort study united states, 2006\u20132010","year":"2013","journal-title":"M MWR Morb Mortal Wkly Rep"},{"issue":"12","key":"ref25","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/jvh.13188","article-title":"Laboratory Reform counteracts the WHO hepatitis C elimination strategy in Germany","volume":"26","author":"J Kramer","year":"2019","journal-title":"Journal of Viral Hepatitis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/MCG.0b013e31818be17c","article-title":"Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients","volume":"43","author":"SX Hu","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jvh.13562","article-title":"Long-term-outcome of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis","volume":"28","author":"T Kumada","year":"2021","journal-title":"Journal of Viral Hepatitis"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.29811","article-title":"Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease","volume":"68","author":"LI Backus","year":"2018","journal-title":"Hepatology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.dld.2014.10.005","article-title":"Extrahepatic manifestations of chronic HCV infection. Review Article","volume":"46","author":"P Cacoub","year":"2014","journal-title":"Digestiv and Liver Disease"},{"issue":"04","key":"ref37","doi-asserted-by":"publisher","first-page":"1240\u20138","DOI":"10.1053\/j.gastro.2011.06.036","article-title":"changes in serum level of HBV-DNA and alanine aminotransferase determine risk for hepatocellular carcinoma","volume":"141","author":"T Chen","year":"2011","journal-title":"Gastroenterology"},{"issue":"21","key":"ref39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3238\/arztebl.2012.0385","article-title":"Screening-part 19 of a series on evaluation of scientific publications","volume":"109","author":"C Spix","year":"2012","journal-title":"Dtsch Aerztebl Int"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13690-021-00609-0","article-title":"Utilization of preventive care among migrants and non-migrants in Germany: results from the representative cross-sectional study \u2018German health interview and examination survey for adults (DEGS1)\u2019","volume":"79","author":"A Starker","year":"2021","journal-title":"Arch Public Health"},{"issue":"11","key":"ref45","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.3390\/v13112327","article-title":"The Practicability of the Xpert HCV Viral Load Fingerstick Point-of-Care Assay in Primary Care Settings","volume":"13","author":"D Petroff","year":"2021","journal-title":"Viruses"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1972-4118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:02:24Z","timestamp":1675814544000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1972-4118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":24,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2023,2,7]]},"published-print":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1972-4118","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}